Check out our most popular compounded medications! Get Started
Verapamil HCl 180 mg Slow Release Capsules (Gluten Free) are compounded using Methocel E4M, a controlled-release polymer. This formulation gradually releases the active ingredient, providing sustained therapeutic effects for conditions such as hypertension, angina pectoris, and various types of tachycardia. The slow release mechanism enhances patient compliance by reducing dosing frequency.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy's Verapamil HCl 180 mg Slow Release Capsules (Gluten Free) is a carefully compounded formulation, specifically designed to manage a variety of cardiovascular conditions. These conditions include hypertension, angina pectoris, atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. The formulation incorporates Methocel E4M, a controlled-release polymer, which guarantees a steady and prolonged release of the active ingredient, verapamil hydrochloride, over an extended duration. This slow release mechanism ensures consistent therapeutic effects, minimizes the need for frequent dosing, and enhances patient compliance, especially for medications that necessitate a controlled and extended release profile.
The active ingredient in this formulation, verapamil hydrochloride, is a calcium channel blocker. It works by inhibiting the influx of calcium into the heart and blood vessel cells. This action results in a reduction in blood pressure and heart rate, effectively relieving the symptoms of the aforementioned cardiovascular conditions. The slow release formulation also reduces the risk of side effects that may be associated with higher doses of verapamil.
It is important to note that this formulation should only be administered under the supervision of a healthcare professional. For any queries or further information about this formulation, please feel free to contact us.
Our formulation is gluten-free, making it suitable for patients with dietary restrictions or sensitivities. We strive to ensure that our formulations are as inclusive as possible, catering to a wide range of patient needs. We are committed to providing high-quality, patient-centered care and are always available to answer any questions or concerns you may have about our products.
Verapamil HCl 180 mg Slow Release Capsules (Gluten Free) are a meticulously compounded formulation, designed to provide a sustained release of the active ingredient, Verapamil, over an extended period of time. This is made possible through the use of Methocel E4M, a controlled-release polymer. The slow release of the medication offers prolonged therapeutic effects, reduces the need for frequent dosing, and improves patient compliance, particularly for those requiring a controlled and extended release profile of their medication.
By blocking calcium channels in the heart and blood vessels, Verapamil helps to lower blood pressure and improve blood flow. It also works to slow the heart rate and reduce the risk of irregular heartbeats.
It is crucial for patients to take this medication as prescribed and to regularly monitor their blood pressure and heart rate. Common side effects of Verapamil include dizziness, headache, nausea, and constipation. Patients should immediately contact their healthcare provider if they experience any unusual symptoms or if their condition worsens. It is also important for patients to inform their healthcare provider of any other medications they are currently taking, as Verapamil may interact with certain drugs.
For any questions or concerns regarding the use of Verapamil HCl 180 mg Slow Release Capsules (Gluten Free) for the treatment of hypertension, angina pectoris, atrial fibrillation, supraventricular tachycardia, or ventricular tachycardia, patients are encouraged to reach out to their healthcare provider. This medication is designed to provide a controlled and prolonged release of Verapamil, offering a more convenient dosing schedule and improved patient compliance. However, it is essential that patients follow their healthcare provider's instructions carefully to ensure the medication's effectiveness and safety.
Verapamil HCl 180 mg Slow Release Capsules (Gluten Free) is a specially compounded formulation that is primarily used in the treatment of various cardiovascular conditions. These include hypertension, angina pectoris, atrial fibrillation, supraventricular tachycardia, and ventricular tachycardia. The medication works by inhibiting certain chemicals in the body that stimulate the heart to beat faster and with more force. This action helps in reducing blood pressure and improving the flow of blood through the heart.
The unique feature of these capsules is their formulation with Methocel E4M, a type of controlled-release polymer. This advanced formulation is designed to gradually release the encapsulated medication or active ingredient over an extended period of time. The slow-release mechanism of this medication offers sustained therapeutic effects, which can lead to a reduction in the frequency of dosing. This can significantly improve patient compliance, especially for medications that require a controlled and prolonged release profile.
Verapamil HCl 180 mg Slow Release Capsules (Gluten Free) is typically administered orally, usually once or twice daily as prescribed by a healthcare provider. It is essential to follow the prescribed dosage and not to miss any doses. The full effects of the medication may not be noticeable for several weeks. Common side effects of Verapamil HCl 180 mg Slow Release Capsules (Gluten Free) may include headache, dizziness, nausea, and fatigue. If any of these side effects are experienced, it is advisable to consult a doctor immediately.
If you have any questions or concerns about Verapamil HCl 180 mg Slow Release Capsules (Gluten Free) or any other medication, please do not hesitate to reach out. It is our commitment to provide comprehensive information to help you better understand your medication.
Verapamil HCl 180 mg Slow Release Capsules is a medication that is encapsulated in a controlled-release polymer, Methocel E4M. This formulation is designed to gradually release the medication over an extended period of time, offering sustained therapeutic effects.
The slow release formulation offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Methocel E4M is a type of controlled-release polymer used in the formulation of these capsules. It is designed to gradually release the encapsulated medication over an extended period of time.
Yes, Verapamil HCl 180 mg Slow Release Capsules are gluten-free.
The slow release mechanism works by gradually releasing the medication over an extended period of time. This is achieved through the use of a controlled-release polymer, Methocel E4M, which encapsulates the medication.
Reduced dosing frequency can improve patient compliance, as it is easier for patients to remember to take their medication. It can also reduce the risk of side effects and improve the overall effectiveness of the medication.
"Improved patient compliance" means that patients are more likely to take their medication as prescribed. This is often achieved by reducing the frequency of dosing, making it easier for patients to remember to take their medication.
A controlled and prolonged release profile refers to the way in which a medication is gradually released into the body over an extended period of time. This is achieved through the use of a controlled-release polymer, such as Methocel E4M.
Patients who require a medication with a controlled and prolonged release profile can benefit from taking Verapamil HCl 180 mg Slow Release Capsules. This includes patients who need sustained therapeutic effects and those who would benefit from reduced dosing frequency.
As with any medication, there may be side effects associated with Verapamil HCl 180 mg Slow Release Capsules. It is important to discuss any potential side effects with your healthcare provider before starting any new medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
